ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Outsourcing

Piramal acquires US solid-dose drug facility

by Rick Mullin
June 26, 2020 | APPEARED IN VOLUME 98, ISSUE 25

 

Piramal Pharma Solutions has agreed to acquire a solid-dose drug production facility in Sellersville, Pennsylvania, from G&W Laboratories. Piramal, an India-based contract manufacturing firm, currently makes solid-dose drugs in the UK and in India. The Sellersville site includes capacity for manufacturing liquids, creams, and ointments. It includes over 20,000 m2 of manufacturing and packaging capacity, as well as quality control and microbiology facilities and research labs.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment